Medivation Inc. buy melinda
Start price
01.12.11
/
50%
€8.98
Target price
01.06.12
€8.75
Performance (%)
93.74%
End price
01.06.12
€17.40
Summary
This prediction ended on 01.06.12 with a price of €17.40. With a performance of 93.74% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Medivation Inc. | - | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% | 70.602% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% | 103.322% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% | 44.593% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% | 64.741% |
Comments by melinda for this prediction
In the thread Medivation Inc. diskutieren
Prostatakrebs
Medivation Inc. entwickelt neue Medikamente zur kleinen Molekülen, um Prostatakrebs zu behandeln, von "Alzheimer, Chorea Huntington (Flaggschiff MDV3100)
(Laufzeit überschritten)